Promisia Healthcare Expects Underlying EBITDAF to Reach NZ$8M in FY27
Promisia Healthcare Expects Underlying EBITDAF to Increase to at Least NZ$8 Million in FY27
Promisia Healthcare Ltd (NZX:PHL) announced that it expects underlying EBITDAF to increase to at least NZ$8 million for fiscal year 2027. The company also introduced a formal dividend policy and is actively working towards an earnings-accretive acquisition in FY27.
Dividend Policy and Growth Strategy
Promisia stated that dividends will be assessed at 20% to 40% of operating free cash flow and are intended to be fully imputed. This move reflects the company's commitment to returning value to shareholders.
The company also emphasized that it is actively pursuing an earnings-accretive acquisition opportunity in FY27. This strategic initiative is part of Promisia's goal to sustain growth momentum and enhance shareholder value.
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.